From the June 2017 article:
Super important paragraph here discussing the specific vaccine-specific antibodies in Travelan and IMM-124 that set it apart from regular bovine colostrum and "are believed to provide the basis for the clinical protection afforded by HBC (today's Travelan and, perfected even more - specifically for inflammation - IMM-124E) in ETEC-challenged volunteers, which included reduced rate of illness (sure did...100% protection) and abdominal pain (reference #24 is Tacket's groundbreaking New England Journal of Medicine published study). The authors then go on to discuss other cross-reactive antibodies found in Travelan and IMM-124E that explain why it is effective against Shigella as well (see the Immuron/DoD NHP press release earlier this year).
- Forums
- ASX - By Stock
- IMC
- Carol Tacket, Travelan, and the New England Journal of Medicine
Carol Tacket, Travelan, and the New England Journal of Medicine, page-9
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
|
|||||
Last
8.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.06M |
Open | High | Low | Value | Volume |
8.7¢ | 8.8¢ | 8.7¢ | $10.89K | 124.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4199 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 16280 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11900 | 0.084 |
1 | 50602 | 0.083 |
1 | 40638 | 0.081 |
2 | 88888 | 0.080 |
1 | 7004 | 0.079 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 16280 | 2 |
0.090 | 4450 | 1 |
0.092 | 11000 | 1 |
0.093 | 38095 | 1 |
0.094 | 164287 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online